Patient Support
Support from AstraZeneca
At AstraZeneca, patient health is at the center of everything we do, and our commitment to patient care goes beyond discovering and developing medicines. An important part of that commitment is the support we provide to patients and health care professionals through the AstraZeneca Cancer Support Network (AZ CSN). AZ CSN provides important information about AstraZeneca oncology products. For more information call 1-866-99-AZCSN (1-866-992-9276), Monday through Friday 8 AM to 6 PM ET, excluding holidays, to speak with a Cancer Support Network representative.
FASLODEX is indicated for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease
progression following antiestrogen therapy.
IMPORTANT SAFETY INFORMATION:
FASLODEX is contraindicated in patients with known hypersensitivity to the drug or to
any of its components. Hypersensitivity reactions, including urticaria and angioedema have been reported in association with FASLODEX.
Click Here for Additional Safety Information
OnCue - News for
oncology professionals
Regularly updated articles cover a range of topics including treatment information, oncology conferences details, and patient resources.
Visit OnCueFeed.com
Get Connected
Request to have an AstraZeneca representative contact you.
Request a Rep